Eli Lilly isn't selling as much Zepbound as expected — and the stock is sinkingByBruce GilUpdatedOctober 30, 2024
Ozempic and other weight loss drugs aren't lowering health care costs yetByBruce GilUpdatedOctober 25, 2024
Ozempic and Alzheimer's, 23andMe's crisis, and Novo Nordisk wants a crackdown: Pharma news roundupByBruce GilPublishedOctober 25, 2024
A non-opioid pain med, a COVID-flu shot combo, and more: 7 drug launches to watch in 2025ByBruce GilPublishedOctober 25, 2024
Ozempic maker Novo Nordisk wants the FDA to crack down on knockoff weight loss drugsByBruce GilUpdatedOctober 23, 2024
Now playing The pill form of Novo Nordisk’s drug Ozempic can cut the risk of heart attacks and strokes, according to a new studyUpdatedOctober 21, 2024
Now playing The pill form of Ozempic can reduce the risk of heart attacks and strokes, study saysByBruce GilUpdatedOctober 21, 2024
I'm a pharmacist. Knockoff Ozempic and other weight loss products have serious hidden risksByC. Michael White / The ConversationPublishedOctober 21, 2024
Ozempic to treat addiction, Walgreens closes stores, weight loss drugs for work: Pharma news roundupByBruce GilPublishedOctober 18, 2024
Ozempic and other weight loss drugs could help treat alcohol and drug addiction, study saysByBruce GilPublishedOctober 17, 2024
Next-gen weight loss drugs will have fewer side effects than Ozempic, pharma CEO saysByBruce GilPublishedOctober 11, 2024
Knockoff weight loss drug sellers are fighting back against Eli Lilly and the FDAByBruce GilPublishedOctober 10, 2024
Ozempic and prescription weight loss drugs: How they work, what they cost, side effects, and everything to knowByBruce GilPublishedOctober 9, 2024
Ozempic for all, Zepbound is back, and the top CEO pay: Pharma news roundupByBruce GilPublishedOctober 4, 2024
